Events & Presentations Upcoming Events ARS Pharmaceuticals 2Q 2026 Financial Results Conference Call Aug 13, 2026 at 4:30 PM EDT Click here for webcast Add to Outlook Add to Google Calendar Past Events Q1 2026 Earnings Call May 15, 2026 at 8:30 AM EDT Click here for webcast Investor Presentations More information is coming soon. Aug 9, 2024 neffy® FDA Approval Call Supporting Materials neffy FDA Approval Call (August 2024) 5.9 MB Mar 7, 2024 at 1:00 PM EST Neffy® Investor Day To view the webcast, click here Supporting Materials neffy investor day presentation (Mar 2024) 10.1 MB Scientific Presentations ACAAI Poster 2025 Well-being & Anxiety Anxiety and well-being related to epinephrine nasal spray versus autoinjector in food allergic patients and caregivers (Greenhawt) 1.1 MB ACAAI Poster 2025 Stability Stability of epinephrine nasal spray under freeze, thaw and extreme temperatures (Golden) 570.7 KB ACAAI Poster 2025 neffy Survey Survey of patients who were prescribed epinephrine nasal spray (Rosenblum) 603.6 KB ACAAI Poster 2025 Sniff Effect of sniff after dosing of epinephrine nasal spray (Spergel) 471.5 KB ACAAI Poster 2025 Same Nostril Rationale for second dose of epinephrine nasal spray to the same nostril (Casale) 567.2 KB ACAAI Poster 2025 Eye Toxicity Low risk of ocular toxicity after unintentional exposure of epinephrine nasal spray (Ellis) 352.6 KB ACAAI Poster 2024 PK Profiles Significant Differences in Pharmacokinetic Profiles Among Epinephrine Products – What is the Mechanism for Efficacy? 579.6 KB ACAAI Poster 2024 HCP interest in neffy Healthcare Professionals Interest in neffy: A Self–Administered Epinephrine Nasal Spray Device 1.1 MB ACAAI Poster 2024 BP Increase Blood Pressure and Pulse Rate Increases Without Concomitant Epinephrine Increases During Acute Allergic Reactions 683.1 KB ACCAI Poster 2024 EPI 10 JP03 neffy, Epinephrine Nasal Spray, Development, from Pharmacokinetics and Pharmacodynamics to Real-World Data in Pediatric Food Allergy Patients 905.4 KB Pagination Current page 1 Page 2 Page 3 Next page next › Last page last »
Investor Presentations More information is coming soon. Aug 9, 2024 neffy® FDA Approval Call Supporting Materials neffy FDA Approval Call (August 2024) 5.9 MB Mar 7, 2024 at 1:00 PM EST Neffy® Investor Day To view the webcast, click here Supporting Materials neffy investor day presentation (Mar 2024) 10.1 MB Scientific Presentations ACAAI Poster 2025 Well-being & Anxiety Anxiety and well-being related to epinephrine nasal spray versus autoinjector in food allergic patients and caregivers (Greenhawt) 1.1 MB ACAAI Poster 2025 Stability Stability of epinephrine nasal spray under freeze, thaw and extreme temperatures (Golden) 570.7 KB ACAAI Poster 2025 neffy Survey Survey of patients who were prescribed epinephrine nasal spray (Rosenblum) 603.6 KB ACAAI Poster 2025 Sniff Effect of sniff after dosing of epinephrine nasal spray (Spergel) 471.5 KB ACAAI Poster 2025 Same Nostril Rationale for second dose of epinephrine nasal spray to the same nostril (Casale) 567.2 KB ACAAI Poster 2025 Eye Toxicity Low risk of ocular toxicity after unintentional exposure of epinephrine nasal spray (Ellis) 352.6 KB ACAAI Poster 2024 PK Profiles Significant Differences in Pharmacokinetic Profiles Among Epinephrine Products – What is the Mechanism for Efficacy? 579.6 KB ACAAI Poster 2024 HCP interest in neffy Healthcare Professionals Interest in neffy: A Self–Administered Epinephrine Nasal Spray Device 1.1 MB ACAAI Poster 2024 BP Increase Blood Pressure and Pulse Rate Increases Without Concomitant Epinephrine Increases During Acute Allergic Reactions 683.1 KB ACCAI Poster 2024 EPI 10 JP03 neffy, Epinephrine Nasal Spray, Development, from Pharmacokinetics and Pharmacodynamics to Real-World Data in Pediatric Food Allergy Patients 905.4 KB Pagination Current page 1 Page 2 Page 3 Next page next › Last page last »
Anxiety and well-being related to epinephrine nasal spray versus autoinjector in food allergic patients and caregivers (Greenhawt) 1.1 MB
Significant Differences in Pharmacokinetic Profiles Among Epinephrine Products – What is the Mechanism for Efficacy? 579.6 KB
Healthcare Professionals Interest in neffy: A Self–Administered Epinephrine Nasal Spray Device 1.1 MB
Blood Pressure and Pulse Rate Increases Without Concomitant Epinephrine Increases During Acute Allergic Reactions 683.1 KB
neffy, Epinephrine Nasal Spray, Development, from Pharmacokinetics and Pharmacodynamics to Real-World Data in Pediatric Food Allergy Patients 905.4 KB